From an analysis of the diagnostic value of FAM64A, we divided patients into high and low FAM64A expression groups and searched for correlations between FAM64A expression and clinical features of pancreatic cancer as well as with patients’ overall survival (OS) and recurrence-free survival (RFS). The gene discussed is PIMREG; the disease is familial pancreatic carcinoma.